Cañete, Baby Girl .

HRN: 29-23-02  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/30/2026
07/06/2026
IV
14mg As LD Then 7mg IV Q12
Q12
T/C NEC
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: